Cargando…

Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis

Detalles Bibliográficos
Autores principales:	Mutsaers, Pim, Selten, Heidi, van Dam, Bastiaan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421516/ https://www.ncbi.nlm.nih.gov/pubmed/25949452 http://dx.doi.org/10.1093/ndtplus/sfq085

Ejemplares similares

Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Transformation of membranous into anti-GBM nephritis
por: Imtiaz, S., et al.
Publicado: (2012)

Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy
por: Bandak, Ghassan, et al.
Publicado: (2014)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study
por: Vigna-Perez, Mónica, et al.
Publicado: (2006)

Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature review
por: Uematsu-Uchida, Mayu, et al.
Publicado: (2019)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Rescue of kidney function in a toddler with anti-GBM nephritis
por: Bjerre, Anna, et al.
Publicado: (2012)

Blockade of CD354 (TREM-1) Ameliorates Anti-GBM-Induced Nephritis
por: Du, Yong, et al.
Publicado: (2016)

A case of anti-GBM nephritis following centipede bites and COVID-19 vaccination
por: Nagai, Kei, et al.
Publicado: (2021)

Disease activity prediction and prognosis of anti-GBM nephritis based on T lymphocyte subset ratios
por: Zhang, Dan, et al.
Publicado: (2021)

Epitope Spreading: The Underlying Mechanism for Combined Membranous Lupus Nephritis and Anti-GBM Disease?
por: Sogbein, Olusola, et al.
Publicado: (2023)

Rituximab Selectively Suppresses Specific Islet Antibodies
por: Yu, Liping, et al.
Publicado: (2011)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Progression to End-Stage Renal Disease Due to IgG4-Related Nephritis Refractory to Rituximab
por: Nguyen, Tien, et al.
Publicado: (2023)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
por: Javed, Tariq, et al.
Publicado: (2012)

Crescentic glomerulonephritis with anti-GBM antibody but no glomerular deposition
por: Sadeghi-Alavijeh, Omid, et al.
Publicado: (2018)

Anti-GBM disease with positive serum anti-GBM antibodies but negative IgG deposition: A case report
por: Kazemzadeh, Kimia, et al.
Publicado: (2023)

Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab
por: Tani, Takashi, et al.
Publicado: (2022)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)

Pulmonary-Renal Syndrome with Negative ANCAs and Anti-GBM Antibody
por: Yamaguchi, Hiroshi, et al.
Publicado: (2013)

Anti-GBM antibody disease sans crescents with thrombotic microangiopathy
por: Gowrishankar, Swarnalata, et al.
Publicado: (2009)

Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination
por: Sacker, Allan, et al.
Publicado: (2021)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy
por: Handunnetti, Sasanka, et al.
Publicado: (2021)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
por: Gilbert, Mileka, et al.
Publicado: (2021)

An Unusual Case of Anti-GBM Antibody Elevation in HIV-Associated Nephropathy
por: Minocha, Vinay, et al.
Publicado: (2014)

Granular Immunofluorescence deposition of IgG in anti-GBM antibody disease
por: Amer, Syed, et al.
Publicado: (2014)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
por: Aftab, Adan, et al.
Publicado: (2022)

Kallikrein Transduced Mesenchymal Stem Cells Protect against Anti-GBM Disease and Lupus Nephritis by Ameliorating Inflammation and Oxidative Stress
por: Li, Yajuan, et al.
Publicado: (2013)

Case Report: Use of Obinutuzumab as an Alternative Monoclonal Anti-CD20 Antibody in a Patient With Refractory Immune Thrombocytopenia Complicated by Rituximab-Induced Serum Sickness and Anti-Rituximab Antibodies
por: Blase, Jennifer R., et al.
Publicado: (2022)

A Case of Simultaneous, Biopsy-Proven, Classic, ANCA-Positive Wegener's Granulomatosis and Anti-GBM Disease, but without Detectible Circulating Anti-GBM Antibodies
por: Gmurczyk, Aleksandra, et al.
Publicado: (2010)

Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies
por: Segelmark, Mårten, et al.
Publicado: (2012)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Comparison of the performance of a chemiluminescence assay and an ELISA for detection of anti-GBM antibodies
por: Tan, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ornja0kkv7o07b8vea0j6kjm1